Monday, July 13, 2020

Cipla gets USFDA nod for rare genetic condition treatment drug

Cipla gets USFDA nod for rare genetic condition treatment drug Cipla#39;s Icatibant injectable pre-filled syringe in the strength of 30mg/3mL is generic version of Shire#39;s Firazyr, the company said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/3epwuOn

No comments:

Post a Comment

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...